Celldex Therapeutics, Inc. · NASDAQ:CLDX
Bellevue Group AG's stake in Celldex Therapeutics, Inc. fell to 1.50% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Bellevue Group AG's stake in Celldex Therapeutics, Inc. fell to 1.50%, 1,200,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 1.50%
- Shares
- 1,200,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bellevue Group AG | 1.50% | 1,200,000 |
| Bellevue Asset Management AG | 1.50% | 1,200,000 |
Source
Related
- Celldex Therapeutics, Inc.
- Bellevue Group AG
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G · Bellevue Group AG · Nov 14, 2025
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026
- Schedule 13G · State Street Corp · May 12, 2026